TCL1A anticorps (N-Term)
Aperçu rapide pour TCL1A anticorps (N-Term) (ABIN631022)
Antigène
Voir toutes TCL1A AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- N-Term
-
Specificité
- TCL1 A antibody was raised against the N terminal of TCL1
-
Purification
- Affinity purified
-
Immunogène
- TCL1 A antibody was raised using the N terminal of TCL1 corresponding to a region with amino acids MAECPTLGEAVTDHPDRLWAWEKFVYLDEKQHAWLPLTIEIKDRLQLRVL
-
-
-
-
Indications d'application
-
WB: 1 µg/mL
Optimal conditions should be determined by the investigator. -
Commentaires
-
TCL1A Blocking Peptide, (ABIN5616535), is also available for use as a blocking control in assays to test for specificity of this TCL1A antibody
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Lyophilized powder. Add distilled water for a 1 mg/mL concentration of TCL0 antibody in PBS
-
Concentration
- Lot specific
-
Buffer
- PBS
-
Conseil sur la manipulation
-
Avoid repeated freeze/thaw cycles.
Dilute only prior to immediate use. -
Stock
- 4 °C/-20 °C
-
Stockage commentaire
- Store at 2-8 °C for short periods. For longer periods of storage, store at -20 °C.
-
-
- TCL1A (T-Cell Leukemia/lymphoma 1A (TCL1A))
-
Autre désignation
- TCL1A
-
Sujet
- TCL1A can enhance the phosphorylation and activation of AKT1, AKT2 and AKT3, promote nuclear translocation of AKT1, enhance cell proliferation, stabilize mitochondrial membrane potential and promote cell survival.
-
Poids moléculaire
- 13 kDa (MW of target protein)
-
Pathways
- Stem Cell Maintenance
Antigène
-